Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Paradigm Biopharmaceuticals Ltd. announced a significant change in the shareholdings of Director Paul Rennie, who now holds a total of 20,924,105 fully paid ordinary shares. The changes were facilitated through his ownership in KZEE Pty Ltd and EAR Investments Pty Ltd, reflecting a substantial interest in the company’s securities.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
